[ad_1] SHENZHEN, Chine, 13 juillet 2024 /PRNewswire/ — Le 5 juillet, le 2e profil de glucose ambulatoire (AGP) et la thérapeutique numérique (DTx), dirigé par le National Innovation Center for Advanced Medical Devices, parrainé par […]
Trending Stories
Fortschrittliche digitale Therapeutika im Diabetes-Management
[ad_1] SHENZHEN, China, 13. Juli 2024 /PRNewswire/ — Am 5. Juli fand das 2. Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx) unter der Leitung des National Innovation Center for Advanced Medical Devices, gesponsert von […]
A Securities Fraud Class Action Lawsuit Has Been Filed Against Teradata Corporation (TDC)
[ad_1] RADNOR, Pa., July 13, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Teradata Corporation (“Teradata”) (NYSE: TDC). The action […]
FSLY Investors Have Opportunity to Lead Fastly, Inc. Securities Fraud Lawsuit
[ad_1] NEW YORK, July 13, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, reminds investors a shareholder filed a class action lawsuit on behalf of all purchasers of securities of Fastly, Inc. […]
Avance de la terapia digital en el manejo de la diabetes
[ad_1] SHENZHEN, China, 13 de julio de 2024 /PRNewswire/ — El 5 de julio, el segundo Perfil Ambulatorio de Glucosa (AGP) y Terapéutica Digital (DTx), dirigido por el Centro Nacional de Innovación para Dispositivos Médicos […]
